I’ve been using Finasteride (7 years), RU58841, Stemoxydine, and 2% Keto shampoo (3 days a week) and my scalp is still really itchy and inflamed. Why?
    4/27/2024

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    RU58841 →

    a potent but unapproved and potentially problematic topical anti-androgen

    Stemoxydine →

    chemical from L'Oreal that encourages hair to enter growth phase

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 7 years
    💧 RU58841 (topical) 1 month
    💧 Ketoconazole shampoo (topical) 2% 3x weekly
    the tone is 😞 negative with no improvement results.

    Other terms

    The user has been using Finasteride for 7 years, RU58841, Stemoxydine, and 2% Ketoconazole shampoo for hair loss treatment but still experiences an itchy and inflamed scalp. They have not yet tried the prescribed oral Minoxidil and are considering lifestyle factors like diet and sleep as potential contributors to the issue.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Clinical Updates in Hair

      research CLINICAL UPDATES IN HAIR

      19 citations , January 1997 in “Dermatologic Clinics”
      This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.
      Alopecia: The Search for Novel Agents Continues

      research Alopecia - the search for novel agents continues

      11 citations , August 1997 in “Expert Opinion on Therapeutic Patents”
      This review discusses nearly 70 patent applications for the treatment of androgenetic alopecia and other hair conditions, highlighting the mechanisms of action explored but reports no clinical results.
      Investigational Medications in the Treatment of Alopecia

      research Investigational medications in the treatment of alopecia

      3 citations , February 2005 in “Expert Opinion on Investigational Drugs”
      This review discusses investigational treatments for androgenetic and chemotherapy-induced alopecia and reports no new clinical results, highlighting the need for further research.

      research Post-finasteride syndrome: our current knowledge

      July 2020 in “Vestnik urologii”
      This review examines the contentious issue of post-finasteride syndrome linked to 5-alpha reductase inhibitors and reports mixed findings on its sexual, physical, and psychological effects; the authors call for more rigorous studies.